Patent · US Active

Imatinib immunoassay

US8263749B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 2, 2011
Grant dateSep 11, 2012
Priority date—
Expiry dateNov 2, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/531
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.